These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20548240)

  • 21. Newborn, carrier, and early childhood screening recommendations for fragile X.
    Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
    Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the Fragile X Syndrome Newborn Screening Landscape.
    Riley C; Wheeler A
    Pediatrics; 2017 Jun; 139(Suppl 3):S207-S215. PubMed ID: 28814541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Pilot Study of Fragile X Syndrome Screening in Pregnant Women and Women Planning Pregnancy: Implementation, Acceptance, Awareness, and Geographic Factors.
    Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
    J Genet Couns; 2017 Jun; 26(3):501-510. PubMed ID: 27714485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
    Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
    Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parent perspectives following newborn screening resulting in diagnoses of fragile X syndrome or fragile X premutation.
    Corbo A; Tzeng JP; Scott S; Cheves E; Cope H; Peay H
    Res Dev Disabil; 2024 May; 148():104719. PubMed ID: 38507982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
    Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
    Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
    Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
    Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conflicts regarding genetic counseling for fragile X syndrome screening: a survey of clinical geneticists and genetic counselors in Israel.
    Lieberman S; Zuckerman S; Levy-Lahad E; Altarescu G
    Am J Med Genet A; 2011 Sep; 155A(9):2154-60. PubMed ID: 21834046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for fragile X gene mutations throughout the life span.
    Hagerman RJ; Hagerman PJ
    JAMA; 2008 Nov; 300(20):2419-21. PubMed ID: 19033593
    [No Abstract]   [Full Text] [Related]  

  • 30. Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
    Ryynänen M; Kirkinen P; Mannermaa A; Saarikoski S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1236-9. PubMed ID: 7726262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population screening for fragile-X syndrome.
    Bonthron D; Strain L
    Lancet; 1993 Mar; 341(8847):769-70. PubMed ID: 8095681
    [No Abstract]   [Full Text] [Related]  

  • 32. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study.
    Inaba Y; Herlihy AS; Schwartz CE; Skinner C; Bui QM; Cobb J; Shi EZ; Francis D; Arvaj A; Amor DJ; Pope K; Wotton T; Cohen J; Hewitt JK; Hagerman RJ; Metcalfe SA; Hopper JL; Loesch DZ; Slater HR; Godler DE
    Genet Med; 2013 Apr; 15(4):290-8. PubMed ID: 23060046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A five-year experience with fragile X screening of high-risk gravid women.
    Wenstrom KD; Descartes M; Franklin J; Cliver SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):789-92. PubMed ID: 10521730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A majority of parents accept newborn screening for fragile X.
    Levenson D
    Am J Med Genet A; 2011 Sep; 155A(9):viii-ix. PubMed ID: 21853527
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review.
    Green JM; Hewison J; Bekker HL; Bryant LD; Cuckle HS
    Health Technol Assess; 2004 Aug; 8(33):iii, ix-x, 1-109. PubMed ID: 15298822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of prenatal carrier screening for fragile X syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    J Matern Fetal Med; 1999; 8(4):168-72. PubMed ID: 10406300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attitudes toward fragile X mutation carrier testing from women identified in a general population survey.
    Anido A; Carlson LM; Sherman SL
    J Genet Couns; 2007 Feb; 16(1):97-104. PubMed ID: 17295053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical and policy issues in newborn screening of children for neurologic and developmental disorders.
    Ross LF
    Pediatr Clin North Am; 2015 Jun; 62(3):787-98. PubMed ID: 26022175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.